	Navigating Hope and Illness Cognition in Advanced Ovarian Cancer Patients: A CSM-Based Phenomenological Study. Psychooncology Long Y, Zhong C, Wen C, He F, Wang Y, Wang C, Xia H, Shi Y, Jin P. PMID: 42287001 [PubMed - indexed for MEDLINE]
	Social Avoidance Trajectories, Core Characteristics and Maintenance Factors in Postoperative Breast Cancer Patients: A Longitudinal Mixed-Methods Study. J Adv Nurs Chunyan H, Xiaoping D, Xiao P, Chao W, Baohua C. PMID: 42286942 [PubMed - as supplied by publisher]
	Preclinical evaluation of a fluorinated bifendate derivative in triple-negative breast cancer: integrated in vitro and in vivo evidence of antitumor activity. BMC Cancer Lin LZ, Huang HY, Peng Y, Lin GQ, Hu J, Jiang Y. PMID: 42286551 [PubMed - as supplied by publisher]
	Adjuvant radiotherapy and skin cancer risk in breast cancer survivors: a nationwide cohort study in Korea. Br J Cancer Chin JH, Kim D, Lee HS, Jeon S, Lee JA, Lee YJ, Bae SY, Park WC, Song JH, Yoon CI. PMID: 42286233 [PubMed - as supplied by publisher]
	RE: Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial. J Natl Cancer Inst Wang X, Xu X, Li Y. PMID: 42286225 [PubMed - as supplied by publisher]
	Anlotinib combined with neoadjuvant chemotherapy for HR+/HER2- breast cancer (ACNTBC): a prospective, single-arm, single-center phase II clinical study with real-world validation. Signal Transduct Target Ther Ding J, Meng H, Wang Y, Zi H, Li M, Chen H, Fan C, Wang S, Zhang L, Shang L, Kong J, Fan J, Wang T. PMID: 42285923 [PubMed - in process]
	Enhancing screening, early diagnosis and treatment initiation of oral, breast and cervical cancer in selected districts of India: an implementation research protocol. BMJ Open Kankaria A, Shukla P, Vijayakumar M, Sachdeva A, Subramanian MJ, Borah PK, Sahoo SS, Nirgude A, Prusty RK, T S S, Asuri K, Verma P, Sharma J, Dhaliwal RS, Begum S, Kaur T, ICMR-NHRP Cancer Screening Group. PMID: 42285578 [PubMed - indexed for MEDLINE]
	FSCL-BC: Federated supervised contrastive learning for breast cancer diagnosis with high sensitivity. Comput Methods Programs Biomed Ahmed F, Sánchez D, Haddi Z, Domingo-Ferrer J. PMID: 42285014 [PubMed - as supplied by publisher]
	Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials. Breast Buonaiuto R, Mangiacotti FP, Giudici F, Tafuro M, Scarfetta R, Longobardi A, Pagliuca M, Caltavituro A, Arecco L, de Azambuja E, Giuliano M, Arpino G, Del Mastro L, De Angelis C, De Laurentiis M, Puglisi F. PMID: 42285001 [PubMed - as supplied by publisher]
	Machine learning defines a histone deacetylase-associated transcriptional prognostic signature with single-cell resolution in breast cancer. Biochem Biophys Res Commun Wang Y, Wang Y, Li Y, Xu Y, Kong L, Liu L, He L, Dai J. PMID: 42284987 [PubMed - as supplied by publisher]
	Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleeding. Int J Gynecol Cancer Olaitan A, Pashayan N, Butler J, Cibula D, Costas L, Davidson EJ, Falconer H, Fotopoulou C, Akapo PK, MacDonald N, Moss E, Mueller M, Rosenthal AN, Sundström K, Hillemanns P, Manchanda R, Sleigh S, Widschwendter M. PMID: 42284981 [PubMed - as supplied by publisher]
	Breast cancer risk-reducing medications - featuring the new kid, "baby tam". Maturitas Klassen CL, Fraker J, Khatri L, Pruthi S. PMID: 42284820 [PubMed - as supplied by publisher]
	Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN study. Gynecol Oncol Gaillard S, Parker J, Broadwater G, Duska L, Knochenhauer H, Ring K, McNally L, Lee PS, Davidson B, Previs R, Moss H, Rogers LW, Dai Y, Berchuck A, Nixon AB, Yi JS, Bookman M, Owzar K, Neff JL, Conejo-Garcia J, Secord AA. PMID: 42284713 [PubMed - as supplied by publisher]
	Constitutional BRCA1 Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study. JCO Precis Oncol Kayali M, Hahnen E, Burges A, Reuss A, Caro-Valenzuela J, de Gregorio N, Heitz F, Schmidt S, Marmé F, Hilpert F, Wimberger P, Kommoss S, Prieske K, Engel C, Buderath P, Dietrich D, Schmutzler R, Sehouli J, Rhiem K, Harter P, Hauke J. PMID: 42284542 [PubMed - indexed for MEDLINE]
	Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort. JCO Precis Oncol Tamaki R, Kogai H, Sagane K, Aoshima K, Li SD. PMID: 42284540 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria. PLoS One Nduka IJ, Okafor CE, Ekwunife OI. PMID: 42284308 [PubMed - indexed for MEDLINE]
	Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. JMIR Res Protoc Liu Z, Yao J, Lu X, Yang Y, Luo B, Wang Y, Cheng X, Jiang W, Yang G, Xiao J, Zhao J, Tian J. PMID: 42284089 [PubMed - in process]
	Multi-modal deep temporal adversarial network based on multi-head self-attention for breast cancer survival prediction. Comput Methods Biomech Biomed Engin Xu H, Xue H, Yuan H, Huang Z. PMID: 42284062 [PubMed - as supplied by publisher]
	Clinical characteristics of medication-related osteonecrosis of the jaw in breast cancer patients receiving zoledronic acid versus denosumab: a retrospective cohort study. Maxillofac Plast Reconstr Surg Kim JS, Hwang Y, Baek S, Ahn KM. PMID: 42283988 [PubMed - as supplied by publisher]
	The role of the microbiome in uterine cancer: insights into tumorigenesis, therapeutic implications, and clinical prospects. J Egypt Natl Canc Inst Zhang Y, Yu X, Shi L, Qi C, Wang H. PMID: 42283913 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 330080

Page 1 of 16504



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy